We are de-risking biomedical innovation, turning biomedical knowledge into social and economic value.
More than three decades later, we remain committed in pursuit of pharmaceutical innovation, providing high quality products and striving to deliver superior business results.
The patient is at the heart of what we do, making decisions regarding biometric innovation is usually a complicated and chaotic procedure as it consists of various product options, various facets to ascertain these on, and multiple evaluations at all levels.
Discover our therapeutic areas, where we continuously invest to innovate and deliver therapeutic solutions for patient’s benefit.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
30
Oct 2026
Flinders University research published in the Journal of Advanced Nursing has examined how specialist palliative care nurses navigate these complex decisions, and found they draw on clinical expertise, ethical judgement, close observation and family engagement to guide care during a patient's final days.
-nazarovsergey_d5f9ed9faaf24fe586cd6ddf5c9a8598-620x480.jpg "Curiox Biosystems strengthens commercial leadership to expand adoption of centrifuge-free sample preparation")
30
Oct 2026
Curiox Biosystems Inc (Curiox), a provider of centrifuge-free (C-FREE™) sample preparation technologies for reproducible, automated flow cytometry workflows, today announced the expansion of its senior commercial team and the formation of a Strategic Advisory Board (SAB).
29
Oct 2026
A cross-sectional study of 1,203 UK adults found that stronger expectations of positive emotions from high-fat, salt and/or sugar foods were weakly associated with poorer diet quality and more frequent comfort eating. Negative emotional expectations about many foods also tracked with comfort eating, but the study did not establish whether eating these foods actually changed mood.
29
Oct 2026
Researchers from Rutgers and other universities analyzed hundreds of online reviews on lemborexant – and learned that about 1 in 4 of the reviewers stopped or planned to stop taking the prescription medication used to treat insomnia.